Technology | 2020.09.09
Smart Meter Announces Availability of the iGlucose® Cellular Connected Blood Glucose Monitoring System for Use in Long-Term Care Facilities During COVID-19
Smart Meter, a diabetes management data, technology and solutions company, announced today that as a result of recent U.S. Federal Drug Administration (FDA) guidance, iGlucose® meters can now be used for individual patients to help reduce infection risk and enable remote patient monitoring (RPM) in long-term care facilities during COVID.
(PRWeb September 09, 2020)
Read the full story at https://www.prweb.com/releases/smart_meter_announces_availability_of_the_iglucose_cellular_connected_blood_glucose_monitoring_system_for_use_in_long_term_care_facilities_during_covid_19/prweb17379011.htm
For more information, please visit
https://www.prweb.com/releases/smart_met[...]ing_covid_19/prweb17379011.htm
